Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
RIGL holding history
Rigel Pharmaceuticals Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −4,409,833−100.0% | Sold out | Holders |
| Q1 2022 | 4,409,833 | $13.2M | <0.1% | +77,225+1.8% | Added | Holders |
| Q4 2021 | 4,332,608 | $11.5M | <0.1% | −42,091−1.0% | Reduced | Holders |
| Q3 2021 | 4,374,699 | $15.9M | <0.1% | −58,325−1.3% | Reduced | Holders |
| Q2 2021 | 4,433,024 | $19.2M | <0.1% | −423,023−8.7% | Reduced | Holders |
| Q1 2021 | 4,856,047 | $16.6M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.